The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 23, 2018
Filed:
Nov. 15, 2013
Applicants:
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Washington University, St. Louis, MO (US);
Inventors:
Dan H. Barouch, Newton, MA (US);
Herbert Virgin, IV, St. Louis, MO (US);
Peter Abbink, Jamaica Plain, MA (US);
Assignees:
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Washington University, St. Louis, MO (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/00 (2006.01); C12N 7/00 (2006.01); C12N 15/74 (2006.01); A61K 39/23 (2006.01); A61K 39/12 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/00 (2013.01); A61K 39/12 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/5258 (2013.01); C12N 2710/10042 (2013.01); C12N 2710/10321 (2013.01); C12N 2710/10343 (2013.01); C12N 2740/15034 (2013.01);
Abstract
The present invention relates to recombinant adenoviruses and vectors thereof. In particular, the adenoviruses are novel simian adenoviruses having a low seroprevalence and high immunogenicity relative to other adenoviruses and vectors thereof. The invention also provides methods for production of the adenoviruses and for the treatment of diseases by administering the adenoviral vector(s) to a subject (e.g., a human).